Trial Outcomes & Findings for Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI) (NCT NCT03885232)
NCT ID: NCT03885232
Last Updated: 2025-04-30
Results Overview
Immunization status was obtained from WA or CO state immunization registry or directly from participating practices. At enrollment, parent/infant dyads completed the Parental Attitudes about Childhood Vaccines short version (PACV-SF), a validated survey scored from 0 to 4. A score of 2 or more represented parent/infant dyad with negative vaccine attitudes. Among parent/infant dyads with negative vaccine attitudes, the child's immunization status at 19 months was calculated based on recommended ages and intervals between doses provided by ACIP for summing late days for each dose of the 8 routine vaccines recommended by 19 months (HepB, rotavirus, DTaP, Hib, pneumococcal conjugate, inactivated polio virus, MMR, and varicella). There was a max of 23 recommended doses for the 8 vaccines - doses varied depending on brand. Total max DUI was a sum of total possible days late for each dose through 19mo(2830 days).Percent DUI was calculated by dividing child's DUI by the total maximum DUI.
COMPLETED
NA
17446 participants
Child's immunization status at 19 months of age
2025-04-30
Participant Flow
Unit of analysis: clinics
Participant milestones
| Measure |
PIVOT With MI
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy was implemented.
|
Control
Clinics delivered standard care.
|
|---|---|---|
|
Overall Study
STARTED
|
9905 12
|
7541 12
|
|
Overall Study
Participants Are Clinicians
|
127 12
|
85 12
|
|
Overall Study
Participants Are Parents Within the Parent/Infant Dyads
|
4889 12
|
3728 12
|
|
Overall Study
Participants Are Infants Within the Parent/Infant Dyads
|
4889 12
|
3728 12
|
|
Overall Study
COMPLETED
|
9799 12
|
7486 12
|
|
Overall Study
NOT COMPLETED
|
106 0
|
55 0
|
Reasons for withdrawal
| Measure |
PIVOT With MI
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy was implemented.
|
Control
Clinics delivered standard care.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
74
|
32
|
|
Overall Study
Staff turnover at enrolled clinics
|
32
|
23
|
Baseline Characteristics
Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
Baseline characteristics by cohort
| Measure |
PIVOT With MI
n=9905 Participants
Clinics in which the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy has been implemented.
|
Control
n=7541 Participants
Care delivered as usual.
|
Total
n=17446 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
Parent/Infant Dyads · <=18 years
|
0 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
0 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
0 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
|
Age, Categorical
Parent/Infant Dyads · Between 18 and 65 years
|
4889 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
3728 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
8617 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
|
Age, Categorical
Parent/Infant Dyads · >=65 years
|
0 Participants
n=4889 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
0 Participants
n=3728 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
0 Participants
n=8617 Participants • Data was collected for parent/infant dyads, where all baseline characteristics refers to parents. Characteristics were not collected for infants. Age was not a measure collected for clinicians.
|
|
Sex/Gender, Customized
Parent/Infant Dyads · Female
|
4138 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
3200 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
7338 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Sex/Gender, Customized
Parent/Infant Dyads · Male
|
567 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
425 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
992 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Sex/Gender, Customized
Parent/Infant Dyads · Unknown
|
184 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
103 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
287 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Sex/Gender, Customized
Clinicians · Female
|
88 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
61 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
149 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Sex/Gender, Customized
Clinicians · Male
|
39 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
24 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
63 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Sex/Gender, Customized
Clinicians · Unknown
|
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Hispanic or Latino
|
551 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
460 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
1011 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Not Hispanic or Latino
|
4,162 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
3158 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
7320 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Parent/Infant Dyads · Unknown or Not Reported
|
176 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
110 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
286 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Clinicians · Hispanic or Latino
|
3 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
5 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
8 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Clinicians · Not Hispanic or Latino
|
123 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
79 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
202 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Ethnicity (NIH/OMB)
Clinicians · Unknown or Not Reported
|
1 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
1 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
2 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · American Indian or Alaska Native
|
62 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
28 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
90 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · Asian
|
228 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
358 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
586 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · Native Hawaiian or Other Pacific Islander
|
14 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
19 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
33 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · Black or African American
|
85 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
63 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
148 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · White
|
3997 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
2931 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
6928 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · More than one race
|
188 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
142 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
330 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Parent/Infant Dyads · Unknown or Not Reported
|
315 Participants
n=4889 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
187 Participants
n=3728 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
502 Participants
n=8617 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · American Indian or Alaska Native
|
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · Asian
|
13 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
8 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
21 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · Black or African American
|
0 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
1 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
1 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · White
|
106 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
74 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
180 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · More than one race
|
6 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
2 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
8 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Race (NIH/OMB)
Clinicians · Unknown or Not Reported
|
2 Participants
n=127 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
0 Participants
n=85 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
2 Participants
n=212 Participants • Participants are split into two groups: parent/infant dyads and clinicians. Demographics for each group were collected separately, as their data is analyzed separately.
|
|
Region of Enrollment
United States
|
9905 participants
n=9905 Participants
|
7541 participants
n=7541 Participants
|
17446 participants
n=17446 Participants
|
PRIMARY outcome
Timeframe: Child's immunization status at 19 months of agePopulation: Infants of parents/caregivers who had negative vaccine attitudes (Parental Attitudes about Childhood Vaccines short form (PACV-SF) score of 2 or higher)
Immunization status was obtained from WA or CO state immunization registry or directly from participating practices. At enrollment, parent/infant dyads completed the Parental Attitudes about Childhood Vaccines short version (PACV-SF), a validated survey scored from 0 to 4. A score of 2 or more represented parent/infant dyad with negative vaccine attitudes. Among parent/infant dyads with negative vaccine attitudes, the child's immunization status at 19 months was calculated based on recommended ages and intervals between doses provided by ACIP for summing late days for each dose of the 8 routine vaccines recommended by 19 months (HepB, rotavirus, DTaP, Hib, pneumococcal conjugate, inactivated polio virus, MMR, and varicella). There was a max of 23 recommended doses for the 8 vaccines - doses varied depending on brand. Total max DUI was a sum of total possible days late for each dose through 19mo(2830 days).Percent DUI was calculated by dividing child's DUI by the total maximum DUI.
Outcome measures
| Measure |
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=586 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
|
Control: Parent/Caregiver and Infant Dyad
n=351 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
|
|---|---|---|
|
Child Immunization Status at 19 Months, 0 Days of Age Characterized as Percent Days Under-immunized (DUI)
|
32 percentage of days under-immunized
Standard Deviation 38
|
24 percentage of days under-immunized
Standard Deviation 32
|
SECONDARY outcome
Timeframe: approximately 6 months post birthPopulation: A subset of parent/infant dyads in both intervention and control clinics who were identified as vaccine hesitant (score of 2 or more on the Parental Attitudes about Childhood Vaccines short form (PACV-SF)) and who completed the post-healthcare visit satisfaction survey.
To assess parental satisfaction with their clinician during a health supervision visit, we asked all vaccine hesitant parents (identified by a Parental Attitudes about Childhood Vaccines-Short Form (PAC-V SF) score of 2 or more) in both both intervention and control arms if they would complete an additional 15-question survey over the phone within 24-48 hours after the completion of a health supervision visit for their child around 6 months of age. Due to COVID-19 restrictions, we had to extend the time frame to within 1 week after a health supervision visit at 2, 4, or 6 months of age. Ratings were on a 7-point Likert scale - Very Poor (1), Poor (2), Fair (3), Good (4), Very Good (5), Excellent (6), Outstanding (7). Overall experience with a rating of "Good (4)" or higher was considered to be a satisfactory visit.
Outcome measures
| Measure |
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=73 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
|
Control: Parent/Caregiver and Infant Dyad
n=46 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
|
|---|---|---|
|
Post-Visit Parental Satisfaction Survey Scored on a 7-point Likert Scale
|
96 % of participants scoring 4 or higher
|
96 % of participants scoring 4 or higher
|
SECONDARY outcome
Timeframe: At Baseline and Post-Intervention (up to 2 years after baseline)Population: Clinicians enrolled across n=24 clinics (n=12 intervention clinics; n=12 control clinics)
To assess changes in clinicians' perceived self-efficacy when discussing vaccines with parents/infant dyads with negative vaccine attitudes, a survey was administered to all participating clinicians at baseline and at study completion asking about vaccine recommendation behaviors and how they perceived their impact on parental decision making regarding vaccines. Self-efficacy was assessed with a 3-part question scored on a Likert Scale - Strongly Disagree, Somewhat Disagree, Somewhat Agree, Strongly Agree. Changes in perceived self-efficacy over time was assessed by comparing the number of clinicians who answered "Strongly Agree" or "Somewhat Agree" to the statement "When parents wish to delay or refuse childhood vaccines for their child, there is not much I can say to change their minds" at baseline and at post-study. Note that fewer clinicians completed the post-study survey due to such factors as retirement and staff turnover.
Outcome measures
| Measure |
PIVOT With MI: Parent/Caregiver and Infant Dyad
n=127 Participants
Parent/Caregiver and Infant dyads at participating clinics trained to use the Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT-MI) communication strategy.
|
Control: Parent/Caregiver and Infant Dyad
n=85 Participants
Parent/Caregiver and Infant dyads at participating clinics in the control arm who received care as usual.
|
|---|---|---|
|
Change in Clinician Self-Efficacy With Parent/Infant Dyads With Negative Vaccine Attitudes - Pre-vs Post-Surveys
Baseline Survey Results
|
54 Participants
|
39 Participants
|
|
Change in Clinician Self-Efficacy With Parent/Infant Dyads With Negative Vaccine Attitudes - Pre-vs Post-Surveys
Post-Study Survey Results
|
23 Participants
|
20 Participants
|
Adverse Events
PIVOT With MI
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sean O'Leary, MD, MPH - Principal Investigator
University of Colorado at Anschutz Medical Campus
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place